Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 70 results.
User Information
Export Records
  1. 1.   A Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab followed by Bevacizumab Monotherapy in Patients with Advanced Kaposi Sarcoma
  2. Ramaswami, Ramya; Uldrick, Thomas S; Polizzotto, Mark N; Wyvill, Kathleen M; Goncalves, Priscila; Widell, Anaida; Lurain, Kathryn; Steinberg, Seth M; Figg, William D; Tosato, Giovanna; Whitby,Denise; Yarchoan, Robert
  3. Clinical cancer research : an official journal of the American Association for Cancer Research. 2019, JUL 15; 25(14): 4238-4247.
  1. 2.   Kaposi sarcoma
  2. Cesarman, Ethel; Damania, Blossom; Krown, Susan E.; Martin, Jeffrey; Bower, Mark; Whitby,Denise
  3. NATURE REVIEWS DISEASE PRIMERS. 2019, Jan 31; 5(1):
  1. 3.   Acute Retroviral Syndrome is Associated with High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments
  2. Crowell, Trevor A; Colby, Donn J; Pinyakorn, Suteeraporn; Fletcher, James L K; Kroon, Eugène; Schuetz, Alexandra; Krebs, Shelly J; Slike, Bonnie M; Leyre, Louise; Chomont, Nicolas; Jagodzinski, Linda L; Sereti, Irini; Utay, Netanya S; Dewar, Robin; Rerknimitr, Rungsun; Chomchey, Nitiya; Trichavaroj, Rapee; Valcour, Victor G; Spudich, Serena; Michael, Nelson L; Robb, Merlin L; Phanuphak, Nittaya; Ananworanich, Jintanat
  3. Clinical Infectious Diseases. 2018, May 15; 66(10): 1540-1549.
  1. 4.   Next-generation in situ hybridization approaches to define and quantify HIV and SIV reservoirs in tissue microenvironments
  2. Deleage, Claire; Chan, Chi N.; Busman-Sahay, Kathleen; Estes, Jake
  3. Retrovirology. 2018, Jan 9; 15(1): 4.
  1. 5.   Initiation of antiretroviral therapy before detection of colonic infiltration by HIV reduces viral reservoirs, inflammation and immune activation
  2. Crowell, T. A.; Fletcher, J. L.; Sereti, I.; Pinyakorn, S.; Dewar, R.; Krebs, S. J.; Chomchey, N.; Rerknimitr, R.; Schuetz, A.; Michael, N. L.; Phanuphak, N.; Chomont, N.; Ananworanich, J.
  3. Journal of the International Aids Society. 2016 19(1): 21163.
  1. 6.   Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir
  2. Koelsch, K. K.; Boesecke, C.; McBride, K.; Gelgor, L.; Fahey, P.; Natarajan, V.; Baker, D.; Bloch, M.; Murray, J. M.; Zaunders, J.; Emery, S.; Cooper, D. A.; Kelleher, A. D.; Team, P. S.
  3. Aids. 2011, Nov; 25(17): 2069-2078.
  1. 7.   Differential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes
  2. Srinivasula, S.; Lempicki, R. A.; Adelsberger, J. W.; Huang, C. Y.; Roark, J.; Lee, P. I.; Rupert, A.; Stevens, R.; Sereti, I.; Lane, H. C.; Di Mascio, M.; Kovacs, J. A.
  3. Blood. 2011, Jul; 118(2): 262-270.
  1. 8.   Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma
  2. Uldrick, T. S.; Whitby, D.
  3. Cancer Letters. 2011, Jun; 305(2): 150-162.
  1. 9.   Association of Host Genetic Risk Factors With the Course of Cytomegalovirus Retinitis in Patients Infected With Human Immunodeficiency Virus
  2. Sezgin, E.; van Natta, M. L.; Ahuja, A.; Lyon, A.; Srivastava, S.; Troyer, J. L.; O'Brien, S. J.; Jabs, D. A.; Studies Ocular Complications, A.
  3. American Journal of Ophthalmology. 2011, Jun; 151(6): 999-1006.
  1. 10.   Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
  2. Hansen, S. G.; Ford, J. C.; Lewis, M. S.; Ventura, A. B.; Hughes, C. M.; Coyne-Johnson, L.; Whizin, N.; Oswald, K.; Shoemaker, R.; Swanson, T.; Legasse, A. W.; Chiuchiolo, M. J.; Parks, C. L.; Axthelm, M. K.; Nelson, J. A.; Jarvis, M. A.; Piatak, M.; Lifson, J. D.; Picker, L. J.
  3. Nature. 2011, May; 473(7348): 523-U270.
  1. 11.   Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV
  2. Musselwhite, L. W.; Sheikh, V.; Norton, T. D.; Rupert, A.; Porter, B. O.; Penzak, S. R.; Skinner, J.; Mican, J. M.; Hadigan, C.; Sereti, I.
  3. Aids. 2011, Mar; 25(6): 787-795.
  1. 12.   CD4 and CD8 T Cell Immune Activation during Chronic HIV Infection: Roles of Homeostasis, HIV, Type I IFN, and IL-7
  2. Catalfamo, M.; Wilhelm, C.; Tcheung, L.; Proschan, M.; Friesen, T.; Park, J. H.; Adelsberger, J.; Baseler, M.; Maldarelli, F.; Davey, R.; Roby, G.; Rehm, C.; Lane, C.
  3. Journal of Immunology. 2011, Feb; 186(4): 2106-2116.
  1. 13.   Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals
  2. Ho, J.; Moir, S.; Wang, W.; Posada, J. G.; Gu, W. J.; Rehman, M. T.; Dewar, R.; Kovacs, C.; Sneller, M. C.; Chun, T. W.; Follmann, D. A.; Fauci, A. S.
  3. Aids. 2011, Jan; 25(3): 295-302.
  1. 14.   HIV-1 Continues To Replicate and Evolve in Patients with Natural Control of HIV Infection
  2. Mens, H.; Kearney, M.; Wiegand, A.; Shao, W.; Schonning, K.; Gerstoft, J.; Obel, N.; Maldarelli, F.; Mellors, J. W.; Benfield, T.; Coffin, J. M.
  3. Journal of Virology. 2010, Dec; 84(24): 12971-12981.
  1. 15.   Mechanisms underlying gamma delta T-cell subset perturbations in SIV-infected Asian rhesus macaques
  2. Harris, L. D.; Klatt, N. R.; Vinton, C.; Briant, J. A.; Tabb, B.; Ladell, K.; Lifson, J.; Estes, J. D.; Price, D. A.; Hirsch, V. M.; Brenchley, J. M.
  3. Blood. 2010, Nov; 116(20): 4148-4157.
  1. 16.   Kaposi Sarcoma (KS)-Associated Herpesvirus MicroRNA Sequence Analysis and KS Risk in a European AIDS-KS Case Control Study
  2. Marshall, V.; Martro, E.; Labo, N.; Ray, A.; Wang, D. A.; Mbisa, G.; Bagni, R. K.; Volfovsky, N.; Casabona, J.; Whitby, D.; Grp, E.-S. S.
  3. Journal of Infectious Diseases. 2010, Oct 1; 202(7): 1126-1135.
  1. 17.   Effect of Host Genetics on the Development of Cytomegalovirus Retinitis in Patients with AIDS
  2. Sezgin, E.; Jabs, D. A.; Hendrickson, S. L.; Van Natta, M.; Zdanov, A.; Lewis, R. A.; Smith, M. W.; Troyer, J. L.; O'Brien, S. J.; Soca Res, G.
  3. Journal of Infectious Diseases. 2010, Aug 15; 202(4): 606-613.
  1. 18.   Effect of Host Genetics on Incidence of HIV Neuroretinal Disorder in Patients With AIDS
  2. Sezgin, E.; Hendrickson, S. L.; Jabs, D. A.; Van Natta, M. L.; Lewis, R. A.; Troyer, J. L.; O'Brien, S. J.; Grp, S. R.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2010, Aug; 54(4): 343-351.
  1. 19.   The Effect of Leflunomide on Cycling and Activation of T-Cells in HIV-1-Infected Participants
  2. Read, S. W.; DeGrezia, M.; Ciccone, E. J.; DerSimonian, R.; Higgins, J.; Adelsberger, J. W.; Starling, J. M.; Rehm, C.; Sereti, I.
  3. Plos One. 2010, Aug; 5(8): 7.
  1. 20.   Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infection
  2. Klatt, N. R.; Harris, L. D.; Vinton, C. L.; Sung, H.; Briant, J. A.; Tabb, B.; Morcock, D.; McGinty, J. W.; Lifson, J. D.; Lafont, B. A.; Martin, M. A.; Levine, A. D.; Estes, J. D.; Brenchley, J. M.
  3. Mucosal Immunology. 2010, Jul; 3(4): 387-398.
  1. 21.   Exposure to HIV-1-encoded Toll-like receptor 8 ligands enhances monocyte response to microbial encoded Toll-like receptor 2/4 ligands
  2. Mureith, M. W.; Chang, J. J.; Lifson, J. D.; Ndung'u, T.; Altfeld, M.
  3. Aids. 2010, Jul; 24(12): 1841-1848.
  1. 22.   Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit
  2. Valentin, A.; von Gegerfelt, A.; Rosati, M.; Miteloudis, G.; Alicea, C.; Bergamaschi, C.; Jalah, R.; Patel, V.; Khan, A. S.; Draghia-Akli, R.; Pavlakis, G. N.; Felber, B. K.
  3. Vaccine. 2010, Feb; 28(8): 1962-1974.
  1. 23.   Immunologic and Virologic Events in Early HIV Infection Predict Subsequent Rate of Progression
  2. Ganesan, A.; Chattopadhyay, P. K.; Brodie, T. M.; Qin, J.; Gu, W. J.; Mascola, J. R.; Michael, N. L.; Follmann, D. A.; Roederer, M.; Infect Dis Clinical Res Program, H. I.
  3. Journal of Infectious Diseases. 2010, Jan; 201(2): 272-284.
  1. 24.   Identification of a Potential Pharmacological Sanctuary for HIV Type 1 in a Fraction of CD4(+) Primary Cells
  2. Valentin, A.; Morrow, M.; Poirier, R. H.; Aleman, K.; Little, R.; Yarchoan, R.; Pavlakis, G. N.
  3. Aids Research and Human Retroviruses. 2010, Jan; 26(1): 79-88.
  1. 25.   Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis
  2. Barozzi, P.; Potenza, L.; Riva, G.; Vallerini, D.; Quadrelli, C.; Bosco, R.; Morselli, M.; Forghieri, F.; Volzone, F.; Rossi, G.; Ferri, C.; Bonini, C.; Ciceri, F.; Bordignon, C.; Whitby, D.; Schulz, T. F.; Torelli, G.; Luppi, M.
  3. Seminars in Arthritis and Rheumatism. 2009, Dec; 39(3): 170-175.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel